or Try an Advanced Search...

    Technical Analysis for VRNA - Verona Pharma plc

    Grade Last Price % Change Price Change
    F 14.85 0.68% 0.10
    VRNA closed up 0.68 percent on Friday, May 10, 2024, on 1.78 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical VRNA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness 0.68%
    Gapped Up Strength 0.68%
    Oversold Stochastic Weakness 0.68%
    Lower Bollinger Band Walk Weakness -0.20%
    Stochastic Reached Oversold Weakness -0.20%
    Earnings Movers Other -0.20%
    Inside Day Range Contraction -0.20%
    Older End-of-Day Signals for VRNA ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    3x Volume Pace 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRNA Chart by TradingView
    Basic chart:

    Profile

    Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders

    Is VRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
    May 10 Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
    May 9 Verona Pharma gets $650M in financing ahead of June FDA decision on COPD asset
    May 9 Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript
    May 9 Verona Pharma GAAP EPS of -$0.04 beats by $0.09
    May 9 Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 9 Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
    May 8 Verona Pharma Q1 2024 Earnings Preview
    May 2 Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
    Apr 25 Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
    See more VRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 23.07
    52 Week Low 11.83
    Average Volume 427,212
    200-Day Moving Average 16.59
    50-Day Moving Average 15.97
    20-Day Moving Average 15.47
    10-Day Moving Average 15.19
    Average True Range 0.57
    RSI (14) 38.65
    ADX 18.95
    +DI 11.76
    -DI 21.72
    Chandelier Exit (Long, 3 ATRs) 14.81
    Chandelier Exit (Short, 3 ATRs) 16.31
    Upper Bollinger Bands 16.40
    Lower Bollinger Band 14.54
    Percent B (%b) 0.16
    BandWidth 11.99
    MACD Line -0.35
    MACD Signal Line -0.29
    MACD Histogram -0.0575
    Fundamentals Value
    Market Cap 1.19 Billion
    Num Shares 79.9 Million
    EPS -0.56
    Price-to-Earnings (P/E) Ratio -26.52
    Price-to-Sales 2981.17
    Price-to-Book 5.16
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.47
    Resistance 3 (R3) 15.48 15.30 15.36
    Resistance 2 (R2) 15.30 15.14 15.29 15.33
    Resistance 1 (R1) 15.07 15.04 15.19 15.06 15.29
    Pivot Point 14.89 14.89 14.94 14.88 14.89
    Support 1 (S1) 14.66 14.73 14.78 14.65 14.41
    Support 2 (S2) 14.48 14.63 14.47 14.37
    Support 3 (S3) 14.25 14.48 14.34
    Support 4 (S4) 14.24